Product Center
Products Center
Jiuhua Huayuan Pharmaceutical's Class 1.1 innovative traditional Chinese medicine, Tongqiao Jingxuan Granules, has obtained clinical approval
Release time:
2025-09-03 10:32
Source:
Recently, Jiuhua Huayuan Pharmaceutical's Class 1.1 innovative traditional Chinese medicine, Tongqiao Jingxuan Granules, received approval for drug clinical trials. Tongqiao Jingxuan Granules are derived from clinical experience prescriptions, based on the "Yilin Gaicuo" ventilation powder and the "Jin Kui Yao Lue" Ze Xie Tang. They treat dizziness from the perspective of liver and spleen, and add drugs that open the orifices and clear the meridians, calm the liver and latent yang, and calm the mind and stabilize the dizziness. They have the effects of soothing the liver and spleen, promoting qi circulation, dispelling dampness and opening the orifices, and calming the mind and stabilizing the dizziness. The approval notice for the clinical trial of Tongqiao Jingxuan Granules further demonstrates the professional strength and technical advantages of Jiuhua Huayuan in the field of traditional Chinese medicine.
Traditional Chinese Medicine believes that ear vertigo is caused by dysfunction of the ear canal. Its clinical characteristics include sudden onset of vertigo, conscious spinning, unstable standing, but clear consciousness, often accompanied by symptoms such as nausea, vomiting, tinnitus, and hearing loss. It belongs to the category of "vertigo" in traditional Chinese medicine and is a special syndrome of "vertigo". It refers to ear diseases mainly characterized by dizziness, vertigo, tinnitus, hearing loss, nausea, and vomiting caused by pathogenic invasion of the ear canal, weakness of the organs, loss of nourishment of the ear canal, or phlegm and turbid water overflowing the ear canal.
Deafness, tinnitus and vertigo are three common clinical symptoms in otology, with a high incidence rate; And it often accompanies and influences each other, bringing not only difficulties in life, study, and work to patients, but also accompanied by psychological trauma. Dizziness is a movement or positional illusion caused by the body's obstruction of spatial positioning. Patients feel their head or surrounding environment rotating or moving, or exhibit a sense of instability or imbalance. Dizziness is one of the common clinical conditions, with 0.5% to 1.0% of the population having experienced dizziness. The incidence rate of men and women over 70 years old was 47% and 61% respectively.
Jiuhua Huayuan Pharmaceutical has always regarded the research and development of innovative products and advanced technologies as its core strategy, committed to scientific breakthroughs and clinical translation in the field of traditional Chinese medicine. The approval of clinical trials for Tongqiao Jingxuan granules not only reflects the continuous accumulation and technological advantages of Jiuhua Huayuan in the research and development of traditional Chinese medicine compound preparations, but also marks important progress in combining syndrome differentiation and modern clinical needs. The variety is expected to fill the market gap in the field of traditional Chinese patent medicines and simple preparations for the treatment of ear vertigo and provide patients with richer and more standardized treatment options. This approval will further consolidate Jiuhua Huayuan's leading position in the field of traditional Chinese medicine ear, nose, and throat treatment, laying a solid foundation for the research and development of innovative traditional Chinese medicines in the future.
Previous Page
